Search Results
Challenges in treating patients with TP53-mutated AML and future outlooks
Challenges in Treating TP53-Mutated AML, Hope on the Horizon
The challenges of treating TP53-mutated AML and MDS
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML
Treatment options for patients with TP53-mutated AML
The challenges of treating patients with MPNs who possess a TP53 mutation
Tolerability and efficacy of magrolimab plus azacitidine in TP53-mutated AML patients
Progress in the treatment of TP53 mutated AML
A Drug to Finally Benefit Patients with TP53 Mutant AML? | David Sallman | ASH 2021 #AML
Outcomes of alloHSCT in TP53-mutated AML and MDS
The benefit of allogeneic transplantation in patients with TP53-mutated AML
Outcomes of TP53-mutant AML with venetoclax and decitabine
